MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/10732748261434396

Медицинская библиотека · Cancer control : journal of the Moffitt Cancer Center · 2026

Five-Year Survival and Determinants of Diffuse Large B-cell Lymphoma in Resource-Limited Settings: The Impact of HIV/AIDS in a Multi-Center Cohort Study.

Kassaw Abel Temeche, Teferi Ephrem Tafesse, Tarekegn Getachew Yitayew, Zerihun Tigabu Eskeziya, Wondm Samuel Agegnew, Moges Tilaye Arega, Zewdu Woretaw Sisay, Tadesse Tesfaye Yimer, Mussie Desalegn Addis, Melese Teferi Bihonegn, Dagnew Samuel Berihun, Birarra Mekuanent Kassa

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BackgroundDiffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma and a leading cause of cancer-related mortality worldwide. Evidence on long-term survival and prognostic determinants remains limited, particularly among people living with HIV. This study evaluated survival outcomes and predictors of mortality among adults with DLBCL in Northwest Ethiopia.MethodsWe conducted a multicenter retrospective cohort study of consecutively enrolled adults with newly histologically confirmed DLBCL diagnosed between August 1, 2020, and July 31, 2025, at three referral hospitals in Northwest Ethiopia. Patients were followed from diagnosis until death, loss to follow-up, or study end. Overall survival (OS) was estimated using the Kaplan-Meier method. Cox proportional hazard regression was used to identify independent predictors of mortality. Subgroup analyses were performed depending on HIV status. Statistical significance was set at P ≤0.05.ResultsA total of 175 patients with DLBCL were included, of whom 31 (17.7%) were HIV-positive. The median survival time was 36 months (IQR: 21-49). The estimated 5-year OS was 25%. Advanced disease (stage IV; AHR = 2.7, 95% CI: 1.1-6.5), HIV-positive status (AHR = 2.3, 95% CI: 1.1-5.0), elevated serum lactate dehydrogenase (LDH) (≥2× upper limit of normal; AHR = 2.2, 95% CI: 1.0-4.9), and delayed initiation of chemotherapy (≥2 months; AHR = 2.6, 95% CI: 1.2-5.8) were independently associated with increased mortality. Among HIV-positive patients, neutropenic fever was the sole independent predictor of death (AHR = 4.3, 95% CI: 1.1-17.4).ConclusionsSurvival among patients with DLBCL in Northwest Ethiopia remains poor, particularly among those presenting with advanced disease, those living with HIV, those that have delayed treatment initiation, and those that have elevated serum LDH - all these parameters were independently associated with increased mortality. Strengthening diagnostic capacity, ensuring equitable access to immunochemotherapy, integrating HIV-oncology services, and prioritizing early treatment initiation are essential to improving outcome.

Для цитирования: Kassaw Abel Temeche, Teferi Ephrem Tafesse, Tarekegn Getachew Yitayew, Zerihun Tigabu Eskeziya, Wondm Samuel Agegnew, Moges Tilaye Arega, Zewdu Woretaw Sisay, Tadesse Tesfaye Yimer, Mussie Desalegn Addis, Melese Teferi Bihonegn, Dagnew Samuel Berihun, Birarra Mekuanent Kassa. Five-Year Survival and Determinants of Diffuse Large B-cell Lymphoma in Resource-Limited Settings: The Impact of HIV/AIDS in a Multi-Center Cohort Study.. Cancer control : journal of the Moffitt Cancer Center. 2026. DOI: 10.1177/10732748261434396.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.